IASLC President Discusses Accomplishments, Adjustments, and The Year Ahead
Dr. Tetsuya Mitsudomi joined the Board of Directors of IASLC in 2011 and has served as its board president since 2019. IASLC awarded Dr. Mitsudomi its Mary J. Matthews Pathology/Translational […] Read more
Finding the Benefits of the Virtual World: A Conversation with Dr. Heather Wakelee
Heather Wakelee, MD, is the President-Elect of the IASLC and will assume presidential responsibilities at the 2021 WCLC in September. She is the Chief of the Division of Oncology at […] Read more
Interim Chief Scientific Officer Dr. Giorgio Scagliotti Brings Vast IASLC Knowledge to Role
Joy CurzioWith a long history in leadership positions at the IASLC, Dr. Scagliotti is fully prepared to help guide the society’s scientific projects through a transition period. Dr. Scagliotti, is professor […] Read more
Prof. Caroline Dive Honored with Mary J. Matthews Pathology/Translational Research Award for Work with CTCs
Leah LawrenceCaroline Dive, CBE, PhD, FBPhS, FMedSci, Director of the CRUK Manchester Institute Cancer Biomarker Centre, University of Manchester, has been recognized by the IASLC with the Mary J. Matthews Pathology/Translational […] Read more
Dr. Pan-Chyr Yang Honored by IASLC for Contributions to Lung Cancer Prevention
Leah LawrencePan-Chyr Yang, MD, PhD, Chair Professor at the National Taiwan University Hospital and Academician of Academia Sinica, Taiwan, will be recognized by the International Association for the Study of Lung […] Read more
Paul A. Bunn, Jr., Scientific Award to Dr. Joan H. Schiller
Lauren Evoy DavisBreath is life. We depend so much on our ability to breathe with ease but, for patients with lung cancer, that is no small task. For her entire career, Joan […] Read more
Revised U.S. Food and Drug Administration Trial Eligibility Guidance: A Major Step Toward Transforming Lung Cancer Clinical Trials
David E. Gerber, MD+more
By now, investigators, sponsors, clinicians, and patients are widely aware of the crisis facing cancer clinical trials. With scientific discoveries occurring more rapidly than ever, there is a growing need […] Read more
Liquid Biopsy: The Key Weapon for Real-Time Monitoring of Patients With NSCLC
Christian Rolfo, MD, PhD, MBA, Drhc+more
Tissue still represents the “gold standard” biosource for molecular profiling of lung cancer. However, the use of tissue samples in clinical practice is associated with several technical and biological limitations. […] Read more
Lung Cancer Screening in Poland Pilot Program Is Restarted After COVID-19 Lockdown
Witold K. Rzyman, MD, PhDDiscussions about lung cancer screening in Poland started in 2006, and between 2008 and 2010 four lung cancer screening programs were independently implemented by thoracic surgeons in Szczecin, Gdańsk, Poznań, […] Read more
In 2020 the U.S. Food and Drug Administration (FDA) launched Project Patient Voice, an online platform for patients and caregivers along with their health care providers to look at patient-reported […] Read more